Eric Schoen's most recent trade in Cassava Sciences Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.86 per share. | 29 Nov 2024 | 59,800 | 11,500 (0%) | 0% | 3.9 | 230,828 | Common Stock |
Cassava Sciences Inc | Schoen Eric | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. | 29 Nov 2024 | 50,000 | 71,300 (0%) | 0% | 1.2 | 59,000 | Common Stock |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.82 per share. | 29 Nov 2024 | 2,000 | 0 (0%) | 0% | 3.8 | 7,640 | Common Stock |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 7,920 | 7,920 | - | - | Common Stock Warrant | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. | 17 Apr 2024 | 1,500 | 21,300 (0%) | 0% | 22 | 33,000 | Common Stock |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 1,000 | 6,920 | - | - | Common Stock Warrant | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 800 | 800 | - | - | Common Stock Warrant | |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 19.95 per share. | 12 Aug 2022 | 2,500 | 19,800 (0%) | 0% | 20.0 | 49,875 | Common Stock |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.03 per share. | 17 Sep 2020 | 10,000 | 25,300 (0%) | 0% | 7.0 | 70,300 | Common Stock |
Cassava Sciences Inc | Eric Schoen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.04 per share. | 17 Sep 2020 | 2,000 | 27,300 (0%) | 0% | 7.0 | 14,080 | Common Stock |